SR9009 (10MG) (50 TABLETS)

Rev-ErbA Receptor Agonist & Circadian Metabolic Switch | Enhanced Mitochondrial Density, Endurance & Lipid Metabolism

Overview:
SR9009 (Stenabolic) is an orally bioavailable synthetic Rev-ErbA receptor agonist engineered to regulate circadian rhythms and metabolic gene expression. By binding to Rev-ErbA protein receptors in skeletal muscle, liver, and adipose tissue, SR9009 increases mitochondrial count (mitochondrial biogenesis), upregulates basal metabolic rate, and accelerates fatty acid oxidation, mimicking the cellular physiological benefits of continuous aerobic exercise.

This product is supplied as a secure bottle containing 50 oral tablets, with each tablet accurately dosed at 10mg of active SR9009.

Unlike standard thermogenic fat burners that stimulate the central nervous system, SR9009 operates at the cellular level by modifying gene transcription. It turns off glucose-storing genes and turns on fat-burning and energy-expenditure pathways.

This results in a dramatic increase in time-to-exhaustion, enhanced oxygen utilization, and accelerated lipid reduction without triggering anxiety, elevated heart rate, or sleep disruption. The 10mg tablet configuration is ideal for managing SR9009’s unique daily timing requirements across 50 tablets.

• Rev-ErbA Activation: Directly triggers master regulatory proteins to boost basal metabolic speed and energy expenditure.
• Mitochondrial Biogenesis: Increases the concentration and functional capacity of energy-producing mitochondria in muscle cells.
• Non-Stimulant Fat Loss: Drives steady lipolysis and glucose uptake into skeletal muscle without central nervous system strain.
• Dramatic Endurance Elevation: Extends stamina, delays lactate accumulation, and increases overall athletic work capacity.
• Non-Hormonal & Zero Suppression: Does not interact with androgen receptors or suppress endogenous testosterone—no PCT required.

• Half-Life & Timing: SR9009 has a very short active elimination half-life of approximately 4 to 5 hours. To maintain stable blood plasma levels, split the daily dose into 2 to 3 micro-doses spread evenly throughout the day (e.g., morning, mid-day, and prior to training).
• Protocol Length: Typically utilized in standard cutting or endurance cycles lasting 6 to 8 weeks.
• Swallowing: Swallow tablets whole with water. Do not crush or chew.

• Non-Hormonal: Does not cause aromatization, estrogenic side effects, or HPTA suppression.
• Circadian Rhythm Syncing: Because Rev-ErbA proteins regulate body clocks, avoid taking doses late at night to prevent minor sleep interference.
• Workout Optimization: Best administered 30 to 45 minutes prior to cardio or intense training sessions for peak aerobic enhancement.